本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vir Biotechnology, Inc.

10.47
-0.2950-2.74%
成交量:128.93萬
成交額:1,335.49萬
市值:17.66億
市盈率:-6.17
高:10.73
開:10.71
低:10.23
收:10.77
52周最高:11.94
52周最低:4.75
股本:1.69億
流通股本:1.30億
量比:1.38
換手率:0.99%
股息:- -
股息率:- -
每股收益(TTM):-1.6972
每股收益(LYR):-3.1619
淨資產收益率:-26.08%
總資產收益率:-14.51%
市淨率:1.80
市盈率(LYR):-3.31

資料載入中...

2026/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/24

重要事件披露

Form 8-K - Current report
2026/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/10

重要事件披露

Form 8-K - Current report